Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Cost of Revenue: 2020-2025

Historic Cost of Revenue for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $1.5 billion.

  • Agilon Health's Cost of Revenue fell 109.37% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 billion, marking a year-over-year increase of 686.27%. This contributed to the annual value of $5.8 billion for FY2024, which is 4574.77% up from last year.
  • According to the latest figures from Q3 2025, Agilon Health's Cost of Revenue is $1.5 billion, which was down 109.37% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Agilon Health's Cost of Revenue ranged from a high of $1.5 billion in Q4 2024 and a low of $140.3 million during Q4 2021
  • For the 5-year period, Agilon Health's Cost of Revenue averaged around $928.4 million, with its median value being $932.8 million (2023).
  • Its Cost of Revenue has fluctuated over the past 5 years, first plummeted by 5210.87% in 2021, then soared by 25856.72% in 2023.
  • Agilon Health's Cost of Revenue (Quarter) stood at $140.3 million in 2021, then soared by 129.69% to $322.2 million in 2022, then skyrocketed by 258.57% to $1.2 billion in 2023, then soared by 31.44% to $1.5 billion in 2024, then fell by 1.92% to $1.5 billion in 2025.
  • Its Cost of Revenue was $1.5 billion in Q3 2025, compared to $1.4 billion in Q2 2025 and $1.4 billion in Q1 2025.